Park Square has placed Frederick Beddingfield III, M.D., Ph.D., as Chief Executive Officer at Rubedo Life Sciences.
| less than a minute read
Rubedo Life Sciences Appoints Former Allergan Executive and Biotechnology Veteran Dr. Frederick Beddingfield III as CEO
Get in touch
Get in touch
Rubedo Life Sciences, a biopharmaceutical company committed to developing first-in-class therapies targeting senescent cells which drive age-related diseases, today announced the appointment of Frederick C. Beddingfield III, M.D., Ph.D., as Chief Executive Officer and board director.
Get in touch
Get in touch
Latest Insights
/Passle/58a5cb8db00e8110e83aa395/MediaLibrary/Images/2026-09-01-21-26-53-841-6a97431d406533fea8d4615c.gif)
/Passle/58a5cb8db00e8110e83aa395/MediaLibrary/Images/2026-09-01-15-07-30-357-6a96ea32ce35c90f7ee74028.jpg)
/Passle/58a5cb8db00e8110e83aa395/MediaLibrary/Images/2026-08-24-14-26-15-201-6a8c5487b4553f6e28c0bcb7.jpg)
/Passle/58a5cb8db00e8110e83aa395/SearchServiceImages/2026-08-19-20-29-57-758-6a8612450e2b381c3863fcf2.jpg)